Evidence map›Paper›PMID 32166012›Full record

ArticleTherapeutic advances in endocrinology and metabolism2020

Favourable serum calcification propensity with intraperitoneal as compared with subcutaneous insulin administration in type 1 diabetes.

Peter R van Dijk, Femke Waanders, Andreas Pasch, Susan J J Logtenberg, Titia Vriesendorp, Klaas H Groenier, Jan-Luuk Hillebrands, Nanno Kleefstra, Rijk O B Gans, Harry van Goor and 1 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Therapeutic advances in endocrinology and metabolism, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 2 pooled it
0.4field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 syntheses or guidelines pooled it, 3 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Peter R van DijkDepartment of Internal Medicine, University Medical Center Groningen, 9713 GZ, HPA AA41, Groningen, The Netherlands.ORCID https://orcid.org/0000-0002-9702-6551
Femke WaandersDepartment of Internal Medicine, Isala, Zwolle, The Netherlands.
Andreas PaschCalciscon AG, Nidau, Switzerland.
Susan J J LogtenbergDepartment of Internal Medicine, Diakonessenhuis, Utrecht, The Netherlands.
Titia VriesendorpIsala, Diabetes Centre, Zwolle, The Netherlands.
Klaas H GroenierIsala, Diabetes Centre, Zwolle, The Netherlands.
Jan-Luuk HillebrandsDepartment of Pathology and Medical Biology, Pathology division, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
Nanno KleefstraDepartment of Internal Medicine, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
Rijk O B GansDepartment of Internal Medicine, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
Harry van GoorDepartment of Pathology and Medical Biology, Pathology division, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
Henk J G BiloDepartment of Internal Medicine, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
University Medical Center Groningen · NLIsala · NLDiakonessenhuis hospital · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSerum calcification propensity can be monitored using the maturation time of calciprotein particles in serum (T

methodsProspective, observational case-control study. Measurements were performed at baseline and at 26 weeks in age and gender matched persons with T1DM.

resultsA total of 181 persons, 39 (21.5%) of which used IP and 142 (78.5%) SC insulin were analysed. Baseline T

conclusionAmong persons with T1DM, IP insulin administration results in a more favourable calcification propensity time then SC insulin. It has yet to be shown if this observation translates into improved cardiovascular outcomes.

Indexed as

cardiovascularinsulinintraperitonealphosphateserum calcification propensitysubcutaneousT50type 1 diabetes mellitus

Identifiers

PMID32166012
PMCPMC7054733
OpenAlexW3009130725

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.